rrx-001 and Prostatic-Neoplasms--Castration-Resistant

rrx-001 has been researched along with Prostatic-Neoplasms--Castration-Resistant* in 1 studies

1 other study(ies) available for rrx-001 and Prostatic-Neoplasms--Castration-Resistant

Article	Year
A Complete Metabolic Response of Metastatic Castration-resistant Neuroendocrine Carcinoma of the Prostate After Treatment with RRx-001 and Reintroduced Platinum Doublets. European urology, 2018, Volume: 73, Issue:2 Topics: Aged; Antineoplastic Agents; Azetidines; Carboplatin; Carcinoma, Neuroendocrine; Humans; Male; Nitro Compounds; Prostatic Neoplasms, Castration-Resistant; Remission Induction	2018